相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
Emmanuel Bachy et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial
Gerald G. Wulf et al.
LEUKEMIA (2021)
Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Results of an Interim Analysis
Jonathan E. Brammer et al.
BLOOD (2021)
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population
Yuko Shirouchi et al.
LEUKEMIA & LYMPHOMA (2021)
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
Andrei Shustov et al.
BLOOD ADVANCES (2021)
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project
Ranjana H. Advani et al.
BLOOD (2021)
Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study
Lorenzo Falchi et al.
BLOOD (2021)
How I Diagnose Angioimmunoblastic T-Cell Lymphoma
Yi Xie et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
Frederick Lansigan et al.
ACTA HAEMATOLOGICA (2020)
Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
E. Domingo-Domenech et al.
BONE MARROW TRANSPLANTATION (2020)
Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT
E. Domingo-Domenech et al.
BONE MARROW TRANSPLANTATION (2020)
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial
Christine Schmitz et al.
HEMATOLOGICAL ONCOLOGY (2020)
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy
Elisa Bossi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Alectinib for relapsed or refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: An open-label phase II trial
Reiji Fukano et al.
CANCER SCIENCE (2020)
Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma
Yasuhiro Suzuki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
Paola Ghione et al.
BLOOD ADVANCES (2020)
The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A plus CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma
Steven M. Horwitz et al.
BLOOD (2020)
Multi-Center Phase II Study of Oral Azacitidine (CC-486) Plus CHOP As Initial Treatment for Peripheral T-Cell Lymphoma (PTCL)
Jia Ruan et al.
BLOOD (2020)
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study
Elizabeth H. Phillips et al.
BONE MARROW TRANSPLANTATION (2019)
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
Tayla B. Heavican et al.
BLOOD (2019)
Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma
Greg Hapgood et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas
Fredrik Ellin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study
Steven I. Park et al.
CANCER (2019)
Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib
Daniel R. Reed et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Central nervous system relapse of systemic ALK-rearranged anaplastic large cell lymphoma treated with alectinib
Samuel B. Tomlinson et al.
LEUKEMIA RESEARCH (2019)
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry
Catalina Amador et al.
BLOOD (2019)
Dose Optimization of Duvelisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Selection of Regimen for the Dose-Expansion Phase
Steven M. Horwitz et al.
BLOOD (2019)
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis
Narendranath Epperla et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Steven Horwitz et al.
LANCET (2019)
Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry
Robert N. Stuver et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma
Neha Mehta-Shah et al.
BLOOD ADVANCES (2019)
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
Anne-Segolene Cottereau et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital
Mary Gleeson et al.
LEUKEMIA & LYMPHOMA (2018)
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
Carlo Gambacorti-Passerini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network
Massimo Federico et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements
Rebecca A. Luchtel et al.
BLOOD (2018)
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
Steven M. Horwitz et al.
BLOOD (2018)
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
G. Fossard et al.
ANNALS OF ONCOLOGY (2018)
Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment
Hideaki Kitahara et al.
ANNALS OF HEMATOLOGY (2017)
A Prospective Cohort Study of Patients With Peripheral T-Cell Lymphoma in the United States
Kenneth R. Carson et al.
CANCER (2017)
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707
Yoshinobu Maeda et al.
HAEMATOLOGICA (2017)
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin
Maria Pamela Dobay et al.
HAEMATOLOGICA (2017)
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study
Yael P. Mosse et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707
Yoshinobu Maeda et al.
HAEMATOLOGICA (2017)
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin
Maria Pamela Dobay et al.
HAEMATOLOGICA (2017)
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma
Barbara Pro et al.
BLOOD (2017)
The addition of etoposide to CHOP is associated with improved outcome in ALK plus adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study
Henrik Cederleuf et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study
Martin Bjerregard Pedersen et al.
BLOOD (2017)
Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma
Kieron Dunleavy et al.
HAEMATOLOGICA (2016)
Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma
Kieron Dunleavy et al.
HAEMATOLOGICA (2016)
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas
Clinton Yam et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort
Petula Nijeboer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients
Tarec Christoffer El-Galaly et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial
Byeong-Bae Park et al.
ANNALS OF HEMATOLOGY (2015)
Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma
S. Horwitz et al.
ANNALS OF ONCOLOGY (2015)
Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease
Amer Beitinjaneh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
Owen A. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma
Zhengzi Qian et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Post-therapy 18F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma
Naoto Tomita et al.
ANNALS OF HEMATOLOGY (2015)
Final Report of a Phase 2 Clinical Trial of Lenalidomide Monotherapy for Patients With T-Cell Lymphoma
Ethan Toumishey et al.
CANCER (2015)
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy
J. S. Abramson et al.
ANNALS OF ONCOLOGY (2014)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar et al.
BLOOD (2014)
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Tianjiao Wang et al.
BLOOD (2014)
Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin
Steven M. Horwitz et al.
BLOOD (2014)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2014)
Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
Fredrik Ellin et al.
BLOOD (2014)
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
Bertrand Coiffier et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma
Cinzia Pellegrini et al.
ONCOLOGIST (2014)
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid®) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial
Franck Morschhauser et al.
EUROPEAN JOURNAL OF CANCER (2013)
CD30 expression in peripheral T-cell lymphomas
Elena Sabattini et al.
HAEMATOLOGICA (2013)
Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial
Gandhi Damaj et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
Sonali M. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Etude des Lymphomes de l'Adulte Trials
David Sibon et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Bertrand Coiffier et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect
A. Dodero et al.
LEUKEMIA (2012)
Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus
Michel Meignan et al.
LEUKEMIA & LYMPHOMA (2012)
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
Dennis D. Weisenburger et al.
BLOOD (2011)
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project
Jan Delabie et al.
BLOOD (2011)
Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
Owen A. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
P. L. Zinzani et al.
ANNALS OF ONCOLOGY (2010)
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation
Michal Sieniawski et al.
BLOOD (2010)
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
Norbert Schmitz et al.
BLOOD (2010)
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
Sally F. Barrington et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010
Michel Meignan et al.
LEUKEMIA & LYMPHOMA (2010)
Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
Peter Reimer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Management of Enteropathy-Associated T-Cell Lymphoma: An Algorithmic Approach
Nitin Babela et al.
CASE REPORTS IN ONCOLOGY (2009)
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
S. Mercadal et al.
ANNALS OF ONCOLOGY (2008)
Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: The Stanford experience
Andy I. Chen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
Nathalie Mourad et al.
BLOOD (2008)
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: A study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
Steven Le Gouill et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study
S. Feyler et al.
BONE MARROW TRANSPLANTATION (2007)
Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases
Klaus Willenbrock et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma:: a prospective study from The Gel-Tamo Study Group
Jose Rodriguez et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission:: the Spanish Lymphoma and Autologous Transplantation Group experience
J. Rodriguez et al.
ANNALS OF ONCOLOGY (2007)
Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.: The GELTAMO experience
Jose Rodriguez et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma
Mark J. Bishton et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Angioimmunoblastic T cell lymphoma: Treatment experience with cyclosporine
Ranjana Advani et al.
LEUKEMIA & LYMPHOMA (2007)
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation
P. Corradini et al.
LEUKEMIA (2006)
Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified
Karen L. Grogg et al.
MODERN PATHOLOGY (2006)
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
Tarun Kewalramani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL) - A new diagnostic marker providing evidence that AITL derives from follicular helper T cells
J Dupuis et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma -: The MD Anderson Cancer Center experience
MP Escalón et al.
CANCER (2005)
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas
G Enblad et al.
BLOOD (2004)
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
A Gallamini et al.
BLOOD (2004)
Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma:: a nation-wide survey
E Jantunen et al.
BONE MARROW TRANSPLANTATION (2004)
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas:: results of the NHL-B1 trial of the DSHNHL
M Pfreundschuh et al.
BLOOD (2004)
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma
S Wöhrer et al.
ANNALS OF ONCOLOGY (2004)
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
P Corradini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification
KJ Savage et al.
ANNALS OF ONCOLOGY (2004)
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype
KW Song et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience
J Rodriguez et al.
ANNALS OF ONCOLOGY (2003)
High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas
AK Blystad et al.
BONE MARROW TRANSPLANTATION (2001)
Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center
J Gale et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
